Target intelligence / Profile preview

Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein (NP)

Target
NP
Molecular classification
Viral protein, Structural protein, RNA-binding protein, Endonuclease
01

Overview

The CCHFV nucleoprotein is central to viral replication by binding genomic RNA into protective complexes. Its unique structure supports both specific recognition of panhandle vRNA structures critical for genome packaging and broader nonspecific interactions with ss/dsRNAs. Its immunogenicity makes it valuable both diagnostically and potentially as part of future vaccines or therapeutics against this severe tick-borne disease.

Other names
Nucleocapsid proteinProtein N
02

Mechanism of action

Unknown, Ribavirin's efficacy remains debated

03

Biological functions

vRNA bindingvRNA encapsidationRibonucleoprotein complex formationGenome packagingModulating host immune responses
04

Disease associations

InfectionCrimean-Congo hemorrhagic fever
05

Safety considerations

CCHF high mortality rateLack of FDA-approved vaccineRibavirin efficacy debated
06

Interacting drugs

Ribavirin

Beyond the preview

Go deeper on Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein (NP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein (NP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call